Growth Metrics

Intelligent Bio Solutions (INBS) Current Leases (2022 - 2025)

Intelligent Bio Solutions' quarterly Current Leases came in at $84659.0 in Q2 2025, down 69.2% year-on-year from $274834.0 in Q2 2024, and down 44.05% quarter-over-quarter from $151322.0 in Q1 2025.

Intelligent Bio Solutions has reported Current Leases for 4 years, with the latest figure at $84659.0 in Q2 2025.

  • For the quarter ending Q2 2025, Current Leases fell 69.2% year-over-year to $84659.0; the trailing twelve-month figure through Jun 2025 stood at $84659.0 (down 69.2% YoY), and the FY2025 full-year result was $84659.0, down 69.2% from the prior year.
  • Current Leases for Q2 2025 stood at $84659.0, down from $151322.0 in the prior quarter.
  • The five-year high for Current Leases was $281565.0 in Q3 2024, with the low at $84659.0 in Q2 2025.
  • Average Current Leases over 4 years is $208668.6, with a median of $223447.0 recorded in 2023.
  • Year-over-year, Current Leases surged 55.91% in 2023 and slumped 69.2% in 2025.
  • Tracing INBS's Current Leases over 4 years: stood at $160826.0 in 2022, then soared by 55.91% to $250751.0 in 2023, then fell by 17.87% to $205945.0 in 2024, then tumbled by 58.89% to $84659.0 in 2025.
  • The last three Current Leases figures came in at $84659.0 (Q2 2025), $151322.0 (Q1 2025), and $205945.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn - 84,659.00

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 84,659.00
Mar 31, 2025 151,322.00
Dec 31, 2024 205,945.00
Sep 30, 2024 281,565.00
Jun 30, 2024 274,834.00
Mar 31, 2024 260,377.00
Dec 31, 2023 250,751.00
Sep 30, 2023 227,414.00
Jun 30, 2023 223,447.00
Mar 31, 2023 174,215.00
Dec 31, 2022 160,826.00